November 17，The one -year approval limit of Zhejiang Tianyuan Bio acquired Zhejiang Tianyuan Bio，But the Ministry of Commerce has not announced the results of approval，The prospect of this multinational M & A case was covered with shadows。November 3, 2009，announcement of Novartis Group, Switzerland，It will acquire 85%of the equity of Zhejiang Tianyuan Biopharmaceutical in Zhejiang Tianyuan Biopharmaceutical，Become the holder of the latter。Novartis acquisition My stake betting appstake online sports bettingof Tianyuan Biology is when the flow of A.，At that time，Tianyuan has obtained the 20 million dose of H1N1 influenza vaccine orders for the Ministry of Industry and Information Technology。With the acquisition of Tianyuan，Novartis is expected to become the first foreign -funded enterprise to enter the domestic Alide vaccine supply sequence。
But to this day，This transaction has not been approved delayed。When the outbreak of A flow，The state hopes that foreign capital can provide technical support，But in the end，Foreign capital does not provide substantial support，This also makes the country's attitude more cautious。The progress of this transaction，Sailing contract is signed for 1 year，But (contract) is locked for 18 months。According to his statement，This acquisition will not have results until 6 months。
November 3, 2009，It will take Tianyuan as the platform，Bring technology and production lines into China，Promote Novartis's business in the domestic vaccine field。At that time，In addition to the acquisition of Tianyuan Biological control equity，Novartis also announced，Planning investment of US $ 1 billion，Construction in Shanghai's largest pharmaceutical research and development center，and invested 250 million US dollars to build a factory located in Changshu。
My stake betting appStake Sports BettingThis is the first major merger of foreign investment in the domestic vaccine industry，Allegable，The acquisition amount is $ 125 million。Previous，Including GlaxoSmithg、Novartis and other foreign capital giants，Always in the Chinese vaccine market。But because it is related to major public health incidents，Novartis and other foreign -funded enterprises have not obtained the qualifications to produce A vaccine in China。Now a year has passed，But the Ministry of Commerce has not disclosed the progress of the approval of this transaction。
China，It is already the third largest vaccine market in the world，Annual industry sales exceeded $ 1 billion。New medical reform in China，It is constantly expanding the domestic pharmaceutical and vaccine market，New medical reform with preventive -oriented，It will inevitably bring great opportunities and markets to the vaccine market。With the improvement of the funding standard for basic public health services per capita，More vaccines will be added to the ranks of national procurement。
but，Foreign -funded companies entering the Chinese vaccine industry，The method adopted is generally exporting its vaccine products produced abroad to the Chinese market。According to the information provided by Novartis at the time，Novartis is the world's fifth largest vaccine producer and the stake online sports bettingstake online sports bettingsecond largest flu vaccine manufacturer，Novartis vaccine includes influenza、Rabies disease、Forest Encephalitis、Treatment of typhoid fever、cholera and hepatitis A，About 800 million doses per year，Sales in 85 countries around the world。But after foreign capital entered the Chinese market in July 2006，Novartis can only provide vaccines for influenza and rabies in China，Business limited。
From the person in charge of this vaccine company，"Come in foreign capital，Mainly staring at the Chinese market，Selling products。6 dollar cost -costing pediatric pneumonia vaccines sell 800 yuan in China，It's completely profitable "，"Facts，Their products of their products can produce，Influenza vaccine is completely self -sufficient in China "。The person in charge of the vaccine manufacturer said，Ding Xiaohang sells Tianyuan creatures for a reason，"He feels no way out，The domestic competitive environment is not good，Just start thinking about what to do in the next step。He once found Zhongsheng Group，Hope that Zhongsheng Group will reorganize，But Zhongsheng Group has never moved。”
Foreign capital sells the sale of Tianyuan creatures，The person in charge of the vaccine manufacturer is quite sighing，Poor living conditions for private enterprises，Unbearable stake online sports bettingMy stake betting apppolicy support。but，"Now，The country is promoting the biomedical industry plan，Permissions the vaccine also attaches great importance to，Put it in a very high position。”
